只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-30 2026-07-31 | IONS IONIS PHARMACEUTICALS INC | Hayden Michael R Director | 买入（P） | 15,000 | US$53.38 | US$800,700.00 | 19,000 | SEC |
| 2026-07-30 2026-07-31 | BMI BADGER METER INC | Callahan Edward F. Officer · VP-Engineering | 买入（P） | 751 | US$135.25 | US$101,571.92 | 1,937 | SEC |
| 2026-07-30 2026-07-31 | KARO Karooooo Ltd. | Calisto Isaias Jose Director,Officer,TenPercentOwner · CEO Executive Chairman | 卖出（S） | 18,630 | US$63.47 | US$118.25万 | 17,819,482 | SEC |
| 2026-07-30 2026-07-31 | WRLD WORLD ACCEPTANCE CORP | Calmes John L Jr Officer · See remarks | 卖出（S） | 2,000 | US$186.00 | US$372,000.00 | 48,334 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 16,508 | US$26.13 | US$431,354.04 | 19,044 | SEC |
| 2026-07-30 2026-07-31 | ACAD ACADIA PHARMACEUTICALS INC | Thompson Elizabeth H.Z. Officer · EVP, Head of Research & Dev | 卖出（S） | 50 | US$26.17 | US$1,308.50 | 18,994 | SEC |
| 2026-07-30 2026-07-31 | ISRG INTUITIVE SURGICAL INC | Brosius Mark Officer · EVP & Chief Mfg and Supply Cha | 卖出（S） | 28 | US$346.83 | US$9,711.24 | 1,294 | SEC |
| 2026-07-30 2026-07-30 | CYTK CYTOKINETICS INC | Callos Andrew Officer · EVP, Chief Commercial Officer | 卖出（S） | 14,000 | US$79.88 | US$111.83万 | 58,555 | SEC |
| 2026-07-29 2026-07-31 | KARO Karooooo Ltd. | Calisto Isaias Jose Director,Officer,TenPercentOwner · CEO Executive Chairman | 卖出（S） | 31,897 | US$64.43 | US$205.52万 | 17,838,112 | SEC |
| 2026-07-29 2026-07-31 | KNSA Kiniksa Pharmaceuticals International, plc | Cole G Bradley Director | 卖出（S） | 3,673 | US$81.43 | US$299,092.39 | 11,672 | SEC |
| 2026-07-29 2026-07-31 | DBVT DBV Technologies S.A. | Mohideen Pharis Officer · Chief Medical Officer | 卖出（S） | 464 | US$2.70 | US$1,252.80 | 144,531 | SEC |
| 2026-07-29 2026-07-30 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 2,850 | US$81.36 | US$231,876.00 | 174,693 | SEC |
| 2026-07-29 2026-07-29 | ISRG INTUITIVE SURGICAL INC | Brosius Mark Officer · EVP & Chief Mfg and Supply Cha | 卖出（S） | 28 | US$360.21 | US$10,085.88 | 1,322 | SEC |
| 2026-07-28 2026-07-29 | KARO Karooooo Ltd. | Calisto Isaias Jose Director,Officer,TenPercentOwner · CEO & Executive Chairman | 卖出（S） | 22,036 | US$64.19 | US$141.44万 | 17,870,009 | SEC |
| 2026-07-28 2026-07-29 | VRSN VERISIGN INC/CA | CALYS JOHN Officer · EVP, Chief Financial Officer | 卖出（S） | 500 | US$281.56 | US$140,777.50 | 31,086.6712 | SEC |
| 2026-07-28 2026-07-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,204 | US$254.07 | US$305,900.88 | 132,429 | SEC |
| 2026-07-28 2026-07-29 | ISRG INTUITIVE SURGICAL INC | Brosius Mark Officer · EVP & Chief Mfg and Supply Cha | 卖出（S） | 28 | US$365.58 | US$10,236.24 | 1,350 | SEC |
| 2026-07-27 2026-07-29 | BEAM Beam Therapeutics Inc. | Simon Amy Officer · Chief Medical Officer | 卖出（S） | 16,667 | US$25.74 | US$429,036.91 | 85,696 | SEC |
| 2026-07-27 2026-07-29 | KARO Karooooo Ltd. | Calisto Isaias Jose Director,Officer,TenPercentOwner · CEO & Executive Chairman | 卖出（S） | 25,913 | US$63.44 | US$164.39万 | 17,892,045 | SEC |
| 2026-07-27 2026-07-29 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie Officer · Chief Medical Officer | 卖出（S） | 1,000 | US$20.00 | US$20,000.00 | 51,776 | SEC |
| 2026-07-27 2026-07-29 | NTRA Natera, Inc. | Moshkevich Solomon Officer · PRESIDENT, CLINICALDIAGNOSTICS | 卖出（S） | 1,010 | US$260.49 | US$263,095.71 | 133,633 | SEC |
| 2026-07-27 2026-07-29 | ISRG INTUITIVE SURGICAL INC | Brosius Mark Officer · EVP & Chief Mfg and Supply Cha | 卖出（S） | 28 | US$344.00 | US$9,632.00 | 1,378 | SEC |
| 2026-07-27 2026-07-28 | (CALX) CALIX, INC | Russo Carl Director,TenPercentOwner | 卖出（S） | 75,000 | US$36.20 | US$271.48万 | 1,569,188 | SEC |
| 2026-07-27 2026-07-28 | ZS Zscaler, Inc. | RUBIN KEVIN Officer · Chief Financial Officer | 卖出（S） | 72 | US$144.74 | US$10,421.54 | 41,829 | SEC |
| 2026-07-27 2026-07-28 | ZS Zscaler, Inc. | RUBIN KEVIN Officer · Chief Financial Officer | 卖出（S） | 75 | US$145.71 | US$10,928.13 | 41,754 | SEC |
| 2026-07-27 2026-07-28 | ZS Zscaler, Inc. | RUBIN KEVIN Officer · Chief Financial Officer | 卖出（S） | 96 | US$146.75 | US$14,088.42 | 41,658 | SEC |
| 2026-07-27 2026-07-28 | ZS Zscaler, Inc. | RUBIN KEVIN Officer · Chief Financial Officer | 卖出（S） | 118 | US$147.74 | US$17,433.06 | 41,540 | SEC |
| 2026-07-27 2026-07-28 | ZS Zscaler, Inc. | RUBIN KEVIN Officer · Chief Financial Officer | 卖出（S） | 142 | US$148.81 | US$21,131.11 | 41,398 | SEC |
| 2026-07-27 2026-07-28 | SOPH SOPHiA GENETICS SA | Menu Philippe Officer · Chief Medical Officer | 卖出（S） | 5,000 | US$5.66 | US$28,305.50 | 223,387 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 7,000 | US$12.02 | US$84,140.00 | 38,300 | SEC |
| 2026-07-24 2026-07-28 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 6,100 | US$12.02 | US$73,322.00 | 206,672 | SEC |
| 2026-07-24 2026-07-28 | N/A Calamos Aksia Hedged Strategies Fund | Calamos Aksia Hedged Strategies Fund (Offshore), Ltd. TenPercentOwner | 买入（P） | 181,099.426 | US$10.46 | US$189.43万 | 1,620,464.2 | SEC |
| 2026-07-24 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.71 | US$146,425.00 | 702,770 | SEC |
| 2026-07-23 2026-07-27 | OLMA Olema Pharmaceuticals, Inc. | Harmon Cyrus Director | 卖出（S） | 12,500 | US$11.58 | US$144,737.50 | 715,270 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Chrysler Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 2,201.011 | US$877.09 | US$193.05万 | 123,267.319 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Ford Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 2,201.011 | US$877.09 | US$193.05万 | 123,267.319 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW GM RETIREES MEDICAL BENEFITS PLAN TenPercentOwner | 买入（P） | 2,201.011 | US$877.09 | US$193.05万 | 123,267.319 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Chrysler Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 3,431.32 | US$877.09 | US$300.96万 | 192,170.6 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Ford Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 3,431.32 | US$877.09 | US$300.96万 | 192,170.6 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW GM RETIREES MEDICAL BENEFITS PLAN TenPercentOwner | 买入（P） | 3,431.32 | US$877.09 | US$300.96万 | 192,170.6 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Chrysler Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 5,654.906 | US$877.09 | US$495.99万 | 316,702.201 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW Ford Retirees Medical Benefits Plan TenPercentOwner | 买入（P） | 5,654.906 | US$877.09 | US$495.99万 | 316,702.201 | SEC |
| 2026-07-21 2026-07-23 | NONE Commonwealth Credit Partners BDC I, Inc. | UAW GM RETIREES MEDICAL BENEFITS PLAN TenPercentOwner | 买入（P） | 5,654.906 | US$877.09 | US$495.99万 | 316,702.201 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 140 | US$542.75 | US$75,984.43 | 211,689 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 280 | US$555.05 | US$155,414.00 | 209,329 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 110 | US$543.79 | US$59,817.22 | 211,579 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 545 | US$544.71 | US$296,869.13 | 211,034 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 275 | US$545.71 | US$150,070.03 | 210,759 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 269 | US$547.08 | US$147,164.20 | 210,490 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 680 | US$547.70 | US$372,434.64 | 209,810 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 47 | US$548.87 | US$25,796.98 | 209,763 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 153 | US$550.01 | US$84,152.11 | 209,610 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 1 | US$550.72 | US$550.72 | 209,609 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 231 | US$50.05 | US$11,562.52 | 29,769 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 459 | US$51.55 | US$23,659.89 | 29,310 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 2,063 | US$52.39 | US$108,084.90 | 27,247 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 2,184 | US$53.42 | US$116,669.06 | 25,063 | SEC |
| 2026-07-17 2026-07-21 | ELVN Enliven Therapeutics, Inc. | Collins Helen Louise Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 63 | US$53.92 | US$3,397.01 | 25,000 | SEC |
| 2026-07-17 2026-07-20 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 416 | US$26.53 | US$11,036.48 | 51,384 | SEC |
| 2026-07-17 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 3,656 | US$37.90 | US$138,562.40 | 298,901 | SEC |
| 2026-07-16 2026-07-20 | NRDY Nerdy Inc. | Callaway Kyle Officer · Chief Accounting Officer | 卖出（S） | 13,377 | US$0.83 | US$11,102.91 | 487,120 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 9,163 | US$36.46 | US$334,082.98 | 308,441 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 5,865 | US$37.26 | US$218,529.90 | 302,576 | SEC |
| 2026-07-16 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 19 | US$37.96 | US$721.24 | 302,557 | SEC |
| 2026-07-16 2026-07-16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 1,233 | US$2.75 | US$3,390.75 | 388,308 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 19 | US$1.55 | US$29.45 | 743,057 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-16 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 2 | US$1.55 | US$3.10 | 75,019 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 11,216 | US$22.01 | US$246,869.77 | 560,721 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 784 | US$22.63 | US$17,744.51 | 559,937 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 3,000 | US$24.00 | US$71,994.90 | 556,937 | SEC |
| 2026-07-15 2026-07-17 | PRIM Primoris Services Corp | MCCALLISTER TERRY D Director | 买入（P） | 19.501 | US$86.66 | US$1,689.96 | 21,144.055 | SEC |
| 2026-07-15 2026-07-17 | HTFL Heartflow, Inc. | Rogers Campbell Officer · Chief Medical Officer | 卖出（S） | 9,219 | US$25.72 | US$237,112.68 | 88,731 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-17 | INM InMed Pharmaceuticals Inc. | Schneeberger Daniel TenPercentOwner | 买入（P） | 1,000 | US$1.56 | US$1,555.00 | 801,000 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,155 | US$36.16 | US$258,724.80 | 338,904 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 7,845 | US$37.04 | US$290,578.80 | 331,059 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 4,465 | US$36.00 | US$160,740.00 | 326,594 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 8,972 | US$36.99 | US$331,874.28 | 317,622 | SEC |
| 2026-07-15 2026-07-17 | MPLT MapLight Therapeutics, Inc. | Foff Erin Pennock Officer · Chief Medical Officer | 卖出（S） | 18 | US$37.54 | US$675.72 | 317,604 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 13,761 | US$1.55 | US$21,329.55 | 743,038 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,389 | US$1.55 | US$2,152.95 | 75,017 | SEC |
| 2026-07-15 2026-07-16 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 793,650 | US$1.26 | US$999,999.00 | 36,912,736 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 400 | US$84.37 | US$33,746.00 | 39,318 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 2,497 | US$85.86 | US$214,385.43 | 36,821 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 3,803 | US$86.68 | US$329,630.35 | 33,018 | SEC |
| 2026-07-15 2026-07-15 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana Officer · Chief Medical Officer | 卖出（S） | 300 | US$87.25 | US$26,175.99 | 32,718 | SEC |
| 2026-07-15 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 6,349 | US$26.61 | US$168,954.51 | 51,384 | SEC |
| 2026-07-14 2026-07-16 | WTI W&T OFFSHORE INC | Gamblin Huan Officer · EVP & Chief Technical Officer | 卖出（S） | 30,000 | US$3.55 | US$106,500.00 | 129,476 | SEC |
| 2026-07-14 2026-07-16 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 2,000 | US$2.65 | US$5,300.00 | 387,075 | SEC |
| 2026-07-14 2026-07-16 | GALT GALECTIN THERAPEUTICS INC | Jamil Khurram Officer · Chief Medical Officer | 卖出（S） | 16,250 | US$5.13 | US$83,284.50 | 0 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 4,882 | US$1.55 | US$7,567.10 | 729,277 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 493 | US$1.55 | US$764.15 | 73,628 | SEC |
| 2026-07-14 2026-07-16 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 15,000 | US$37.54 | US$563,146.50 | 2,665,000 | SEC |
| 2026-07-14 2026-07-16 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 13,315 | US$37.54 | US$499,886.38 | 40,000 | SEC |
| 2026-07-14 2026-07-16 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 17,974 | US$6.43 | US$115,554.85 | 259,527 | SEC |
| 2026-07-14 2026-07-16 | TOI Oncology Institute, Inc. | Podnos Yale Officer · Chief Medical Officer | 卖出（S） | 5,478 | US$6.35 | US$34,785.30 | 259,527 | SEC |
| 2026-07-14 2026-07-15 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 82,116 | US$4.48 | US$367,879.68 | 0 | SEC |
| 2026-07-13 2026-07-15 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 1,033 | US$4.67 | US$4,824.11 | 60,238 | SEC |
| 2026-07-13 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 14,058 | US$27.58 | US$387,716.83 | 57,733 | SEC |
| 2026-07-13 2026-07-14 | LQDA Liquidia Corp | Saggar Rajeev Officer · Chief Medical Officer | 卖出（S） | 703 | US$71.39 | US$50,187.17 | 181,022 | SEC |
| 2026-07-13 2026-07-14 | LQDA Liquidia Corp | Saggar Rajeev Officer · Chief Medical Officer | 卖出（S） | 9,223 | US$71.52 | US$659,628.96 | 171,799 | SEC |
| 2026-07-13 2026-07-14 | CRC California Resources Corp | Bys Jay A. Officer · EVP & Chief Commercial Officer | 卖出（S） | 11,907 | US$54.00 | US$642,978.00 | 159,424 | SEC |
| 2026-07-13 2026-07-14 | SOPH SOPHiA GENETICS SA | Menu Philippe Officer · Chief Medical Officer | 卖出（S） | 5,000 | US$5.70 | US$28,505.00 | 228,387 | SEC |
| 2026-07-13 2026-07-14 | ANIP ANI PHARMACEUTICALS INC | Cook Meredith Officer · SR. VP, GENERAL COUNSEL & SEC. | 卖出（S） | 500 | US$81.84 | US$40,920.00 | 77,390 | SEC |
| 2026-07-10 2026-07-14 | NTAP NetApp, Inc. | O'Callahan Elizabeth M Officer · EVP, Chief Admin. Officer | 卖出（S） | 1,000 | US$170.92 | US$170,920.00 | 31,297 | SEC |
| 2026-07-10 2026-07-13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 1,700 | US$2.70 | US$4,590.00 | 385,075 | SEC |
| 2026-07-10 2026-07-13 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina Officer · Chief Legal Officer | 卖出（S） | 15,000 | US$17.61 | US$264,121.50 | 179,090 | SEC |
| 2026-07-10 2026-07-13 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 731 | US$3.11 | US$2,273.41 | 61,271 | SEC |
| 2026-07-10 2026-07-13 | INDV Indivior Pharmaceuticals, Inc. | Heidbreder Christian Officer · Chief Scientific Officer | 卖出（S） | 18,586 | US$41.14 | US$764,628.04 | 209,337 | SEC |
| 2026-07-09 2026-07-13 | ADIL ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP TenPercentOwner | 买入（P） | 10,053 | US$2.79 | US$28,047.87 | 383,375 | SEC |
| 2026-07-09 2026-07-13 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina Officer · Chief Legal Officer | 卖出（S） | 15,000 | US$18.32 | US$274,746.00 | 194,090 | SEC |
| 2026-07-09 2026-07-13 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 8,266 | US$3.38 | US$27,939.08 | 60,540 | SEC |
| 2026-07-09 2026-07-13 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 2,464 | US$90.25 | US$222,376.00 | 60,299 | SEC |
| 2026-07-09 2026-07-10 | URGN UroGen Pharma Ltd. | Schoenberg Mark Officer · Chief Medical Officer | 卖出（S） | 10,000 | US$40.00 | US$400,000.00 | 119,763 | SEC |
| 2026-07-09 2026-07-10 | OCC OPTICAL CABLE CORP | SMITH TRACY G Officer · EVP and CFO | 卖出（S） | 16,453 | US$17.23 | US$283,485.19 | 329,826 | SEC |
| 2026-07-09 2026-07-10 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 2,171 | US$30.30 | US$65,781.30 | 57,733 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Czibere Akos Officer · Chief Medical Officer | 卖出（S） | 14,800 | US$27.13 | US$401,484.04 | 35,200 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Czibere Akos Officer · Chief Medical Officer | 卖出（S） | 30,829 | US$27.95 | US$861,735.29 | 4,371 | SEC |
| 2026-07-08 2026-07-10 | AKTS Aktis Oncology, Inc. | Czibere Akos Officer · Chief Medical Officer | 卖出（S） | 4,371 | US$28.71 | US$125,481.79 | 0 | SEC |
| 2026-07-08 2026-07-09 | SNDX Syndax Pharmaceuticals Inc | Metzger Michael A Director,Officer · Chief Executive Officer | 卖出（S） | 32,375 | US$24.24 | US$784,776.48 | 484,843 | SEC |
| 2026-07-08 2026-07-09 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 18,531 | US$3.52 | US$65,229.12 | 52,274 | SEC |
| 2026-07-08 2026-07-09 | CNXC Concentrix Corp | Caldwell Christopher A Director,Officer · President and CEO | 买入（P） | 1,000 | US$21.25 | US$21,249.70 | 358,382 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | Kordasiewicz Holly B. Officer · EVP, Chief Development Officer | 卖出（S） | 362 | US$84.30 | US$30,516.60 | 22,096 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | Diaz Allene M. Director | 卖出（S） | 10,111 | US$85.42 | US$863,637.13 | 3,811 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | BENNETT C FRANK Officer · EVP, Chief Scientific Officer | 卖出（S） | 5,536 | US$83.58 | US$462,693.34 | 75,018 | SEC |
| 2026-07-07 2026-07-09 | IONS IONIS PHARMACEUTICALS INC | BENNETT C FRANK Officer · EVP, Chief Scientific Officer | 卖出（S） | 15,000 | US$85.46 | US$128.19万 | 0 | SEC |
| 2026-07-07 2026-07-09 | IRWD IRONWOOD PHARMACEUTICALS INC | Silver Ronald Officer · PFO & PAO | 卖出（S） | 127,890 | US$4.52 | US$578,062.80 | 313,680 | SEC |
| 2026-07-07 2026-07-09 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 10,580 | US$3.33 | US$35,231.40 | 70,805 | SEC |
| 2026-07-07 2026-07-09 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake Director | 卖出（S） | 40,000 | US$3.96 | US$158,500.00 | 6,218,287 | SEC |
| 2026-07-07 2026-07-09 | DLO dLocal Ltd | Kanovich Sebastian Director | 卖出（S） | 25,700 | US$15.50 | US$398,350.00 | 0 | SEC |
| 2026-07-07 2026-07-08 | APPN APPIAN CORP | Calkins Matthew W Director,Officer,TenPercentOwner · CEO and President | 卖出（S） | 37,515 | US$24.61 | US$923,244.15 | 1,731,629 | SEC |
| 2026-07-07 2026-07-08 | APPN APPIAN CORP | Calkins Matthew W Director,Officer,TenPercentOwner · CEO and President | 卖出（S） | 12,485 | US$25.07 | US$312,998.95 | 1,719,144 | SEC |
| 2026-07-07 2026-07-08 | PALI PALISADE BIO, INC. | Jones Mitchell Lawrence Officer · Chief Medical Officer | 卖出（S） | 51,880 | US$2.05 | US$106,535.58 | 94,009 | SEC |
| 2026-07-07 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 11,369 | US$89.03 | US$101.22万 | 69,587 | SEC |
| 2026-07-07 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 9,288 | US$89.44 | US$830,718.72 | 60,299 | SEC |
| 2026-07-07 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 3,956 | US$87.17 | US$344,844.52 | 80,956 | SEC |
| 2026-07-07 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 20,000 | US$38.37 | US$767,456.00 | 2,680,000 | SEC |
| 2026-07-07 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 6,685 | US$38.37 | US$256,522.17 | 53,315 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 3,124 | US$121.67 | US$380,097.08 | 44,057 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 1,048 | US$122.43 | US$128,306.64 | 43,009 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 528 | US$123.84 | US$65,387.52 | 42,481 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 300 | US$124.94 | US$37,482.00 | 42,181 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 426 | US$85.28 | US$36,329.28 | 60,684 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 385 | US$86.34 | US$33,240.90 | 60,299 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 8,786 | US$85.35 | US$749,885.10 | 70,389 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 10,090 | US$86.32 | US$870,968.80 | 60,299 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 2,474 | US$87.03 | US$215,312.22 | 60,299 | SEC |
| 2026-07-06 2026-07-08 | ORIC Oric Pharmaceuticals, Inc. | Heyman Richard A. Director | 卖出（S） | 300 | US$12.00 | US$3,600.00 | 212,772 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 12,134 | US$121.65 | US$147.61万 | 202,175 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 4,181 | US$122.34 | US$511,503.54 | 197,994 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,975 | US$123.74 | US$244,386.50 | 196,019 | SEC |
| 2026-07-06 2026-07-08 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,710 | US$124.79 | US$213,390.90 | 194,309 | SEC |
| 2026-07-06 2026-07-08 | INSM INSMED Inc | Flammer Martina M.D. Officer · Chief Medical Officer | 卖出（S） | 4,854 | US$109.02 | US$529,183.08 | 67,934 | SEC |
| 2026-07-06 2026-07-08 | INSM INSMED Inc | Flammer Martina M.D. Officer · Chief Medical Officer | 卖出（S） | 7,448 | US$110.60 | US$823,748.80 | 60,486 | SEC |
| 2026-07-06 2026-07-07 | DRTS Alpha Tau Medical Ltd. | Levy Raphi Officer · Chief Financial Officer | 卖出（S） | 2,270 | US$14.00 | US$31,782.50 | 90,180 | SEC |
| 2026-07-06 2026-07-07 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 卖出（S） | 9,022 | US$3.51 | US$31,667.22 | 81,385 | SEC |
| 2026-07-06 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 10,000 | US$38.00 | US$380,000.00 | 2,700,000 | SEC |
| 2026-07-06 2026-07-07 | ZS Zscaler, Inc. | Schlossman Robert Officer · Chief Legal Officer | 卖出（S） | 122 | US$150.00 | US$18,300.00 | 69,244 | SEC |
| 2026-07-06 2026-07-07 | SOPH SOPHiA GENETICS SA | Menu Philippe Officer · Chief Medical Officer | 卖出（S） | 7,393 | US$5.16 | US$38,156.01 | 233,387 | SEC |
| 2026-07-06 2026-07-07 | NBP NovaBridge Biosciences | Xu Cong Claire Officer · SVP, Clinical Development | 卖出（S） | 4,485 | US$0.89 | US$3,991.65 | 298,101 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan Officer · EVP, Chief Commercial Officer | 卖出（S） | 1,541 | US$519.00 | US$799,779.00 | 11,001 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania Officer · EVP, Chief Reg. & Quality Off. | 卖出（S） | 1,500 | US$524.99 | US$787,485.00 | 45,321 | SEC |
| 2026-07-02 2026-07-07 | REGN REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F Director | 卖出（S） | 200 | US$650.15 | US$130,030.00 | 17,303 | SEC |
| 2026-07-02 2026-07-07 | STTK Shattuck Labs, Inc. | Shukla Abhinav A. Officer · Chief Technical Officer | 卖出（S） | 410 | US$7.01 | US$2,874.10 | 86,380 | SEC |
| 2026-07-02 2026-07-07 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP TenPercentOwner | 买入（P） | 7,851 | US$3.54 | US$27,792.54 | 90,407 | SEC |
| 2026-07-02 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 65,000 | US$37.39 | US$243万 | 2,710,000 | SEC |
| 2026-07-02 2026-07-07 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc. TenPercentOwner | 卖出（S） | 25,000 | US$37.39 | US$934,627.50 | 60,000 | SEC |
| 2026-07-02 2026-07-07 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio Director | 卖出（S） | 3,000 | US$40.00 | US$120,000.00 | 19,225 | SEC |
| 2026-07-02 2026-07-07 | IMNM Immunome Inc. | Lechleider Robert Officer · Chief Medical Officer | 卖出（S） | 22,714 | US$21.95 | US$498,572.30 | 48,091 | SEC |
| 2026-07-02 2026-07-07 | IMNM Immunome Inc. | Lechleider Robert Officer · Chief Medical Officer | 卖出（S） | 16,214 | US$22.76 | US$369,030.64 | 31,877 | SEC |
| 2026-07-02 2026-07-07 | IMNM Immunome Inc. | Lechleider Robert Officer · Chief Medical Officer | 卖出（S） | 16,072 | US$23.44 | US$376,727.68 | 15,805 | SEC |
| 2026-07-02 2026-07-06 | DRTS Alpha Tau Medical Ltd. | Levy Raphi Officer · Chief Financial Officer | 卖出（S） | 17,873 | US$13.00 | US$232,397.26 | 90,180 | SEC |
| 2026-07-02 2026-07-06 | ANIP ANI PHARMACEUTICALS INC | CAREY STEPHEN P. Officer · SVP & CFO | 卖出（S） | 3,313 | US$86.00 | US$284,918.00 | 177,543 | SEC |
| 2026-07-02 2026-07-06 | RGNX REGENXBIO Inc. | PAKOLA STEVE Officer · Chief Medical Officer | 卖出（S） | 2,161 | US$13.64 | US$29,476.04 | 213,009 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman, LLC TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Cayman Fund, L.P. TenPercentOwner | 买入（P） | 1,460 | US$1.55 | US$2,263.00 | 724,395 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity, LLC TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 2026-07-02 2026-07-02 | INM InMed Pharmaceuticals Inc. | Vivo Opportunity Fund Holdings, L.P. TenPercentOwner | 买入（P） | 147 | US$1.55 | US$227.85 | 73,135 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BCAL | 71,002 | 2,400 | 83,922.1254 | 84.60% | B, Q, N |
| CALX | 171,890.5634 | 0 | 223,523.5254 | 76.90% | B, Q, N |
| CALM | 269,853.3354 | 364 | 361,811.3281 | 74.58% | B, Q, N |
| CALI | 35,028.6422 | 0 | 47,175.0869 | 74.25% | Q, N |
| CAL | 95,432.9395 | 0 | 140,327.0851 | 68.01% | B, Q, N |
| CALY | 168,467.8263 | 0 | 282,673.2915 | 59.60% | B, Q, N |
| CALC | 106,385 | 0 | 180,127.9474 | 59.06% | B, Q, N |
| GCAL | 8,724.1541 | 0 | 16,610.4624 | 52.52% | Q |
| TCAL | 22,886.8717 | 0 | 84,969.2162 | 26.94% | Q, N |
| CALF | 32,116.4181 | 0 | 153,786.5964 | 20.88% | B, Q, N |
| FCAL | 364.0206 | 0 | 8,954.1634 | 4.07% | Q |